Interleukin-2 receptors in patients with lung carcinoma metastasis undergoing treatment with disodium-clodronate. Preliminary research.
Mazzarino
C
C
General Pathology Institute, University of Catania, Italy.
Nicosia
A
A
Garraffo
C
C
Tantillo
F
F
Monte
V
V
Girlando
A
A
Malaponte
G
G
D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D004002:Clodronic Acid / Q000627:therapeutic use*; D004273:DNA, Neoplasm / Q000096:biosynthesis; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000276:immunology* / Q000473:pathology; D009362:Neoplasm Metastasis; D011869:Radioligand Assay; D015375:Receptors, Interleukin-2 / Q000378:metabolism*; D013936:Thymidine / Q000378:metabolism
D050071:Bone Density Conservation Agents; D004273:DNA, Neoplasm; D015375:Receptors, Interleukin-2; D004002:Clodronic Acid; D013936:Thymidine